Intellectual Property India Publishes Patent Application for 'Il13ra2-Targeting Herpes Simplex Virus And Anti-Il13ra2 Antibody Or Antigen-Binding Fragment Thereof' Filed by The University Of Tokyo; and Uchida, Hiroaki

MUMBAI, India, April 25 -- Intellectual Property India has published a patent application (202517029724 A) filed by The University Of Tokyo; and Uchida, Hiroaki, Tokyo, on March 28, for 'il13ra2-targeting herpes simplex virus and anti-il13ra2 antibody or antigen-binding fragment thereof.'

Inventor(s) include Uchida, Hiroaki; and Tahara, Hideaki.

The application for the patent was published on April 25, under issue no. 17/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides an IL13RA2-targeting herpes simplex virus in which an anti-IL13RA2 antibody or an antigen-binding fragment thereof is presented on the viral surface. Also provided is an anti-IL13RA2 antibody or an antigen-binding...